Effects of MK-801 on clozapine-induced potentiation of excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits

European Journal of Pharmacology

Volumn 395, Issue 1, 2000, Pages 37-42

  Kubota, Takashi ^a   Jibiki, Itsuki ^a   Enokido, Fusako ^a   Nakagawa, Haruo ^a   Watanabe, Ken ichiro ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Clozapine induced potentiation; Haloperidol; Long term potentiation; MK 801; NMDA receptor; Perforant path dentate gyrus pathway

Indexed keywords

CLOZAPINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; MALE; NONHUMAN; PERFORANT NERVE TRACT; PRIORITY JOURNAL; PSYCHOSIS; RABBIT; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DENTATE GYRUS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EVOKED POTENTIALS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; LONG-TERM POTENTIATION; MALE; PERFORANT PATHWAY; RABBITS;

EID: 0034696894     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00150-3     Document Type: Article

References (15)

1. Abraham W.C., Mason S.E. Effects of the NMDA receptor/channel antagonists CPP and MK801 on hippocampal field potentials and long-term potentiation in anesthetized rats. Brain Res. 462:1988;40-46.
2. Arvanov V.L., Liang X., Schwartz J., Grossman S., Wang R.Y. Clozapine and haloperidol modulate NMDA and non-NMDA receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J. Pharmacol. Exp. Ther. 283:1997;226-234.
3. Corbett R., Camacho F., Woods A.T., Kerman L.L., Fishkin R.J., Brooks K., Dunn R.W. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology. 120:1995;67-74.
4. Daly D.A., Moghaddam B. Actions of haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci. Lett. 152:1993;61-64.
5. Farber N., Foster J., Duhan N.L., Olney J.W. Olanzapine and fluperlapinemimic clozapine in preventing MK-801 neurotoxicity. Schizophr. Res. 21:1996;33-37.
6. Haller E., Binder R.L. Clozapine and seizures. Am. J. Psychiatry. 147:1990;1069-1071.
7. Jibiki I., Wakita S., Kubota T., Kurokawa K., Fukushima T., Yamaguchi N. Haloperidol-induced blockade of induction of long-term potentiation in perforant path-dentate gyrus pathway in chronically prepared rabbits. Pharmacol. Biochem. Behav. 46:1993;847-852.
8. Kornhuber J., Kornhuber M.E. Presynaptic dopaminergic modulation of cortical input to the striatum. Life Sci. 39:1986;669-674.
9. Krug M., Chepkova A.N., Geyer C., Ott T. Aminergic blockade modulates long-term potentiation in the dentate gyrus of freely moving rats. Brain Res. Bull. 11:1983;1-6.
10. Kubota T., Jibiki I., Fukushuma T., Kurokawa K., Yamaguchi N. Carbamazepine-induced blockade of induction of long-term potentiation in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Neurosci. Lett. 170:1994;171-174.
11. Kubota T., Jibiki I., Kishizawa S., Kurokawa K. Clozapine-induced potentiation of synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Neurosci. Lett. 211:1996;21-24.
12. Maura G., Rotaccatagliata R., Ulivi M., Raiteri M. Serotonin-glutamate interaction in rat cerebellum: involvement of 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 145:1988;31-38.
13. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
14. Rupniak N.M.J., Hall M.D., Mann S., Kilpatrick G., Jenner P., Marsden C.D. Chronic treatment with clozapine unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Boil. Pharmacol. 34:1985;2755-2763.
15. Yamamoto B.K., Pehek E.A., Meltzer H.Y. Brain region effects of clozapine on amino acid and monoamine transmission. J. Clin. Psychiatry. 55(suppl. 8-14):1994.